S.A. Mason LLC Abb Vie Inc. Transaction History

S.A. Mason LLC

$185 Million
Q3 2024

A detailed history of S.A. Mason LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, S.A. Mason LLC holds 12,641 shares of ABBV stock, worth $2.15 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

12,641

Previous 12,623 0.14%

Holding current value

$2.15 Million

Previous $2.17 Million 15.29%

% of portfolio

1.35%

Previous 1.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$163.84 - $199.33 $2,949 - $3,587	18 Added 0.14%	12,641 $2.5 Million
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $52,009 - $60,735	336 Added 2.73%	12,623 $2.17 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $3,196 - $3,642	20 Added 0.16%	12,287 $2.24 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $11,420 - $12,862	-83 Reduced 0.67%	12,267 $1.9 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $73,207 - $84,748	-548 Reduced 4.25%	12,350 $1.84 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $30,946 - $35,639	214 Added 1.69%	12,898 $2.06 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $4,979 - $5,971	-36 Reduced 0.28%	12,684 $0
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $22,949 - $26,322	-171 Reduced 1.33%	12,720 $1.71 Million
Q2 2022 Jul 07, 2022	BUY	$137.62 - $174.96 $6,192 - $7,873	45 Added 0.35%	12,891 $1.97 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $73,380 - $91,045	556 Added 4.52%	12,846 $2.08 Million
Q4 2021 Jan 04, 2022	BUY	$107.43 - $135.93 $1,718 - $2,174	16 Added 0.13%	12,290 $1.66 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $78,523 - $89,135	738 Added 6.4%	12,274 $1.32 Million
Q2 2021 Jul 07, 2021	SELL	$105.21 - $117.21 $210 - $234	-2 Reduced 0.02%	11,536 $1.3 Million
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $1,636 - $1,801	-16 Reduced 0.14%	11,538 $1.25 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $7,405 - $9,997	-92 Reduced 0.79%	11,554 $1.24 Million
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $687 - $806	8 Added 0.07%	11,646 $1.02 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $586 - $785	8 Added 0.07%	11,638 $1.14 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $4,257 - $6,454	-66 Reduced 0.56%	11,630 $886,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $843,632 - $1.06 Million	11,696 New	11,696 $1.04 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.

Account